Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001193125-15-026515
Filing Date
2015-01-30
Accepted
2015-01-30 06:53:14
Documents
15

Document Format Files

Seq Description Document Type Size
1 FORM F-3 d860664df3.htm F-3 319745
2 EX-4.1 d860664dex41.htm EX-4.1 91782
3 EX-4.2 d860664dex42.htm EX-4.2 11751
4 EX-4.4 d860664dex44.htm EX-4.4 13692
5 EX-4.6 d860664dex46.htm EX-4.6 12240
6 EX-4.8 d860664dex48.htm EX-4.8 11519
7 EX-4.10 d860664dex410.htm EX-4.10 12002
8 EX-4.12 d860664dex412.htm EX-4.12 14078
9 EX-4.14 d860664dex414.htm EX-4.14 34796
10 EX-4.15 d860664dex415.htm EX-4.15 8720
11 EX-23.1 d860664dex231.htm EX-23.1 1734
12 GRAPHIC g860664ex4_14pg001.jpg GRAPHIC 7699
13 GRAPHIC g860664ex4_15pg001.jpg GRAPHIC 9294
14 GRAPHIC g860664ex4_1logo.jpg GRAPHIC 8773
15 GRAPHIC g860664tx_pg003.jpg GRAPHIC 7161
  Complete submission text file 0001193125-15-026515.txt   579015
Mailing Address LEVEL 1 16 - 20 EDGEWORTH DAVID AVE HORNSBY NSW C3 2077
Business Address LEVEL 1 16 - 20 EDGEWORTH DAVID AVE HORNSBY NSW C3 2077 01161298780088
NOVOGEN LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 0630
Type: F-3 | Act: 33 | File No.: 333-201767 | Film No.: 15560733
SIC: 2834 Pharmaceutical Preparations